CS2164 exerts an antitumor effect against human Non-Hodgkin's lymphomas in vitro and in vivo. [electronic resource]
Producer: 20190924Description: 356-362 p. digitalISSN:- 1090-2422
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Aurora Kinase B -- antagonists & inhibitors
- Cell Cycle Checkpoints -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Humans
- Lymphoma, Non-Hodgkin -- drug therapy
- MAP Kinase Signaling System -- drug effects
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Naphthalenes
- Phenylenediamines -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- Quinolines -- pharmacology
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Tumor Stem Cell Assay
- Vascular Endothelial Growth Factor Receptor-2 -- antagonists & inhibitors
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.